๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pyridazine derivatives as novel acyl-coa:cholesterol acyltransferase (acat) inhibitors

โœ Scribed by Arianna Gelain


Book ID
102343911
Publisher
Journal of Heterocyclic Chemistry
Year
2005
Tongue
English
Weight
96 KB
Volume
42
Category
Article
ISSN
0022-152X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Acyl-CoA:cholesterol acyltransferase (E.C.2.3.1.26, ACAT) is a microsomial enzyme that catalyses the formation of cholesteryl esters by acylation of cholesterol with long chain fatty acylCoA [1].

ACAT plays important roles in cellular homeostasis and in the early stages of atherosclerosis. Therefore, ACAT inhibitors have been identified as useful agents in the treatment of hypercholesterolemia, atherosclerosis and coronary diseases [2]. In addition, recently their application has been proposed for Alzheimer's disease [3].


๐Ÿ“œ SIMILAR VOLUMES


Acyl CoA:cholesterol acyltransferase (AC
โœ Richard G. Wilde; Jeffrey T. Billheimer ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 232 KB

A series of compounds bearing two heterocyclic substituents were prepared, and evaluated for inhibition of aeyl-CoA:cholesterol acyltransferase (ACAT). The heterocyclic groups were chosen for dual potency against hepatic and macrophage cell ACAT. Several examples of ACAT-balanced compounds were disc